Financial Ratios

KIMIA BIOSCIENCES LTD.

NSE : NABSE : 530313ISIN CODE : INE285U01025Industry : Pharmaceuticals & DrugsHouse : Private
BSE52.810.98 (+1.89 %)
PREV CLOSE ( ) 51.83
OPEN PRICE ( ) 54.00
BID PRICE (QTY) 0.00 (0)
OFFER PRICE (QTY) 0.00 (0)
VOLUME 1564
TODAY'S LOW / HIGH ( )51.18 54.00
52 WK LOW / HIGH ( ) 31.9958.4
NSE
This Company is not listed in NSE
Select year
ParticularsMar2023Mar2022Mar2021Mar2020Mar2019
Operational & Financial Ratios
   Earnings Per Share (Rs)-1.98-0.781.080.302.64
   CEPS(Rs)-1.27-0.161.480.663.39
   DPS(Rs)0.000.000.000.000.00
   Book NAV/Share(Rs)1.153.153.902.862.39
   Tax Rate(%)24.5126.217.77-12.63-1.30
Margin Ratios
   Core EBITDA Margin(%)-3.960.516.314.195.93
   EBIT Margin(%)-6.34-1.106.723.536.18
   Pre Tax Margin(%)-9.64-4.024.171.154.05
   PAT Margin (%)-7.28-2.963.851.304.10
   Cash Profit Margin (%)-4.68-0.615.292.865.27
Performance Ratios
   ROA(%)-8.28-3.445.311.836.24
   ROE(%)-91.91-22.2232.1916.47243.83
   ROCE(%)-14.30-2.3216.138.9416.94
   Asset Turnover(x)1.141.161.381.411.52
   Sales/Fixed Asset(x)2.853.184.685.135.55
   Working Capital/Sales(x)20.2411.086.924.765.49
Efficiency Ratios
   Fixed Capital/Sales(x)0.350.310.210.190.18
   Receivable days86.33105.16108.76114.09113.91
   Inventory Days121.0688.7060.5162.5249.92
   Payable days164.94140.43108.06100.5895.41
Valuation Parameters
   PER(x)0.000.0035.1867.1413.46
   PCE(x)-25.54-233.4625.6030.4910.47
   Price/Book(x)28.1511.959.746.9814.86
   Yield(%)0.000.000.000.000.00
   EV/Net Sales(x)1.601.751.681.190.87
   EV/Core EBITDA(x)-54.80139.4220.5623.2611.87
   EV/EBIT(x)-25.32-158.2724.9733.5414.11
   EV/CE(x)1.762.012.091.471.25
   M Cap / Sales1.201.421.350.870.55
Growth Ratio
   Net Sales Growth(%)2.89-5.8924.8613.1723.08
   Core EBITDA Growth(%)-340.65-85.57100.09-21.52107.29
   EBIT Growth(%)-491.19-115.43137.67-35.28165.46
   PAT Growth(%)-152.56-172.55269.62-64.18131.48
   EPS Growth(%)-152.56-172.55262.15-88.72131.48
Financial Stability Ratios
   Total Debt/Equity(x)9.692.732.442.547.39
   Current Ratio(x)1.081.181.381.581.56
   Quick Ratio(x)0.450.580.911.051.03
   Interest Cover(x)-1.92-0.382.631.482.91
   Total Debt/Mcap(x)0.340.230.250.370.59

© NIRMAL BANG. All rights reserved

Designed , Developed & Content Powered by Accord Fintech Pvt. Ltd.

Open an Account
FOR AFREE *DEMAT & BROKING ACCOUNT

Please fill in the details below

Close X

(Note - You will receive a call from our sales executive)

CLOSE X

RISK DISCLOSURES ON DERIVATIVES

  • 9 out of 10 individual traders in equity Futures and Options Segment, incurred net losses.
  • On an average, loss makers registered net trading loss close to ₹ 50,000.
  • Over and above the net trading losses incurred, loss makers expended an additional 28% of net trading losses as transaction costs.
  • Those making net trading profits, incurred between 15% to 50% of such profits as transaction cost.

Source:

1. SEBI study dated January 25, 2023 on “Analysis of Profit and Loss of Individual Traders dealing in equity Futures and Options (F&O) Segment”, wherein Aggregate Level findings are based on annual Profit/Loss incurred by individual traders in equity F&O during FY 2021-22.